Abstract

Biodiversity of natural products supplies an enormous source of drug discovery leads. It is the general belief that the nature of natural products are highly likely to provide therapeutic hits, because there are a greater number of stereocentres that intensifies scaffold diversity as supplied by the organic structures of more fused, bridged and spirocarbocyclic rings [1]. The successful isolation of resveratrol from grapes has remarked the benefits in promoting metabolic health by consuming red wines, suggesting the pharmaceutical values as a potential treatment for metabolic syndromes [2]. There are approximately 40% of all medicines especially, 60% of anticancer agents and 80% of antimicrobials available in clinical use are either natural products or their semisynthetic derivatives [3]. Synthetic forms of natural products have become the new trends of pharmaceutical development. Nowadays, classical drugs originally sourced from natural products become ‘unnatural’, such as anticancer Toxal (extracted from the Pacific yew tree) [4] and antimalarial Artemisinin (extracted from annual wornwood) [5], could be biosynthesized exploit multiple advanced techniques of genetic, enzymology and microbiology. However, such kind of success underlying the principle of ‘make and test enough compounds and the right one will be found’ often spend decades of time [6]. As reflected by many researchers, the challenge remains as the probability of finding the right one amongst the vast drug-like chemical space must be small, like looking for a needle in a haystack. Back to the middle of 1990s, Verdine [7] has already dictated the insights on the success of nature drugs discovery relies on building libraries in a combinatorial ways streamline with advances in techniques such as cell culture, compound extraction, high-throughput screening and synthesis. Combinatorial chemistry is now matured in drug development with the utilization of revolutionary computational simulation [8] and engineered biosynthesis [9]. In the era of 2000, the field of Ethnopharmacology has rapidly emerged. It studies the medicinal values of botanical substances, considering traditional herbal medicines (THM) as a major delivery. Historically, the use of herbal remedies has been served as a complementary but unique medical system around the world. Most herbal medicines are complex mixtures of largely unknown chemical composition. They may be decoctions, infusions, or extracts of one or many herbs. Given that the active ingredients of many herbs and their physiological actions are yet to be defined, the practice of THM is principally based on the experience accumulated for thousands of years. The body of science takes the initiative to turn the experience-based THM into a scientific evidence-based context. This is an intricate task requiring huge amounts of manpower and efforts to screen, isolate, characterize and standardize the infinite number of chemical compounds and variants using empirical methods. From a single herb, the number of chemical structures extractable could be ranged from 10-folds to hundreds. Taking a well-known medicinal mushroom called

Highlights

  • Biodiversity of natural products supplies an enormous source of drug discovery leads

  • It is the general belief that the nature of natural products are highly likely to provide therapeutic hits, because there are a greater number of stereocentres that intensifies scaffold diversity as supplied by the organic structures of more fused, bridged and spirocarbocyclic rings [1]

  • Classical drugs originally sourced from natural products become ‘unnatural’, such as anticancer Toxal [4] and antimalarial Artemisinin [5], could be biosynthesized exploit multiple advanced techniques of genetic, enzymology and microbiology

Read more

Summary

Introduction

Biodiversity of natural products supplies an enormous source of drug discovery leads. There are approximately 40% of all medicines especially, 60% of anticancer agents and 80% of antimicrobials available in clinical use are either natural products or their semisynthetic derivatives [3]. Back to the middle of 1990s, Verdine [7] has already dictated the insights on the success of nature drugs discovery relies on building libraries in a combinatorial ways streamline with advances in techniques such as cell culture, compound extraction, high-throughput screening and synthesis.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call